Adam Harvey
Company: Ferring Pharmaceuticals
Job title: Associate Director of Clinical Research, Microbiome & GI Clinical Therapeutic Area
Seminars:
Final Results from PUNCH CD3-OLS, an Open-Label Clinical Trial of REBYOTA (Fecal Microbiota Live-jslm) in Patients with Recurrent C. Difficile Infection 9:30 am
Download the Full Event Guide to see session detailsRead more
day: Conference Day One